Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China · Delayed Price · Currency is CNY 95.53
+2.93 (3.16%)
May 6, 2026, 3:00 PM CST
SHA:688578 Revenue
Shanghai Allist Pharmaceuticals had revenue of 1.58B CNY in the quarter ending March 31, 2026, with 44.19% growth. This brings the company's revenue in the last twelve months to 5.67B, up 44.95% year-over-year. In the year 2025, Shanghai Allist Pharmaceuticals had annual revenue of 5.19B with 45.80% growth.
Revenue (ttm)
5.67B
Revenue Growth
+44.95%
P/S Ratio
7.58
Revenue / Employee
2.85M
Employees
1,989
Market Cap
42.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.19B | 1.63B | 45.80% |
| Dec 31, 2024 | 3.56B | 1.54B | 76.29% |
| Dec 31, 2023 | 2.02B | 1.23B | 155.14% |
| Dec 31, 2022 | 791.00M | 260.91M | 49.22% |
| Dec 31, 2021 | 530.09M | 529.53M | 94,409.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition